KPTI
Karyopharm Therapeutics Inc
1.80$
+5.3%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.2% | -38.4% | +942.2% | +1,790.1% | +34.8% | +164.3% | +94.1% | -25.1% | -7.0% | -0.5% | +0.6% | |
| – | +62.6% | -11.1% | +23.4% | +50.4% | -98.5% | +12.4% | +25.8% | +53.2% | -5.2% | +21.5% | -1.0% | |
| – | – | -38.4% | +942.2% | -8,264.2% | – | +173.8% | +95.9% | -26.4% | -7.1% | -1.3% | +0.6% | |
| – | +62.6% | -11.1% | +23.4% | +50.4% | -24.2% | +23.3% | +6.6% | -7.6% | -6.7% | +3.2% | -12.3% | |
| – | +35.3% | +11.0% | +3.9% | +96.4% | +115.8% | +19.9% | +13.8% | +1.1% | -9.3% | -12.5% | -8.9% | |
| – | +56.9% | -7.1% | +19.2% | +59.1% | +8.3% | +21.7% | +9.9% | -3.5% | -8.0% | -4.4% | -10.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +89,400.0% | +44.6% | +25.0% | +54.2% | +527.6% | +73.5% | -4.0% | -4.0% | -4.7% | +57.1% | +22.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -54.7% | -58.7% | +53.8% | +672.5% | -13.3% | +37.7% | -12.5% | -82.4% | -24.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.